Zhaoke Ophthalmology’s Partner Tenpoint Therapeutics Receives FDA Approval for its Presbyopia Drug YUVEZZI™ Leverages Global Network to Accelerate APAC Access

Zhaoke Ophthalmology Advances Commercialization of BRIMOCHOL™ PF for Presbyopia in Singapore and Vietnam through Partnerships with AFT and Senju

Zhaoke Ophthalmology’s Myopia Drug, Atropine Sulfate Eye Drops, Accepted for Registration Evaluation in Australia

Zhaoke Ophthalmology Partners with TSH Biopharm to Bring Innovative Presbyopia Therapy BRIMOCHOLTM PF to Taiwan Region

Zhaoke Ophthalmology Donates HK$200,000 to the “Support Fund for Wang Fuk Court in Tai Po” to Assist with the Post-Tragedy Rescue Operations